Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TFXthis companyTeleflex Incorporated	$152.88	-6.01×	1.74×	2.73×	25.71×	-26.4%	56.2%	12.8%	-45.4%	-29.0%	4.1%	4.5%	0.87×	7.71×	2.55×	2.54×	1.1%	5	2	2	C
ARWRArrowhead Pharmaceuticals, Inc.	$47.49	-2,827.05×	9.9×	5.56×	28.84×	-253.1%	100.0%	11.9%	-0.2%	-0.3%	4.6%	3.4%	0.79×	0.85×	1.1×	4.86×	0.0%	3	2.67	1	D+
KRYSKrystal Biotech, Inc.	$299.97	34.82×	5.85×	18.34×	33.92×	78.8%	92.6%	41.5%	52.6%	16.8%	13.1%	2.6%	0.01×	-2.48×	0×	9.95×	0.0%	4	40.92	4	A-
MMSIMerit Medical Systems, Inc.	$87.89	40.62×	3.29×	3.44×	17.06×	42.5%	48.7%	12.2%	8.5%	8.1%	5.6%	4.1%	0.57×	1.35×	6.97×	4.34×	0.0%	5	4.23	3	B
PCVXVaxcyte, Inc.	$65.17	-8.2×	2.34×	0×	-8.54×	-100.9%	0.0%	0.0%	0.0%	-28.5%	-32.5%	-10.7%	0.09×	-0.07×	0×	7.91×	0.0%	0	13.18	2	C
PTCTPTC Therapeutics, Inc.	$64.46	8.85×	-29.43×	3.49×	8.75×	-1377.4%	95.9%	49.5%	39.4%	-332.5%	33.4%	6.8%	-13.19×	1.94×	5.63×	2.35×	0.0%	4	0.75	2	C
Peer median	—	8.85×	3.29×	3.49×	17.06×	-100.9%	92.6%	12.2%	8.5%	-0.3%	5.6%	3.4%	0.09×	0.85×	1.1×	4.86×	0.0%	4	4.23	2	—